Introduction
The nuclear receptor subfamily 2 group F member 1 gene (NR2F1) encodes a conserved nuclear receptor protein that regulates transcription. Mutations in NR2F1 and deletions comprising NR2F1 are the cause of Bosch-Boonstra-Schaaf optic atrophy syndrome (MIM#615722), which is an autosomal-dominant disorder characterized by optic atrophy and intellectual disability caused by loss-of-function mutations in NR2F1 [1] . Recently, 20 more patients with pathogenic NR2F1 variants were reported, and 40% of these patients had seizures, as well as visual and cognitive deficits [2] . Infantile spasms associated with NR2F1 point mutations have been reported in five patients, including our case [2] [3] [4] . Here, we present a long-term outcome of our patient, since there has been no reported clinical description of West syndrome associated with an NR2F1 mutation.
Case report
A 26-year-old woman was born after an uncomplicated pregnancy to a healthy, non-consanguineous Japanese parents. The family history was non-contributory and there were no apparent neurological conditions; the patient has one healthy older brother. The neonatal period was unremarkable. The patient's birth weight and body length were 3445 g (+1.1 SD) and 49.5 cm (+ 0.5 SD), respectively. Infantile spasms developed at 4 months of age. Soon after, she was diagnosed with West syndrome because she had brief spasms in clusters and the interictal electroencephalography (EEG) showed hypsarrhythmia at our hospital. The neurological examination was unremarkable, except for mild spastic quadriparesis and mild developmental delay. Laboratory examinations, including a full blood count, routine blood chemistry, urinalysis, amino acid, blood lactate and pyruvate levels, and urine organic acids, and routine cerebrospinal fluid examination were within the normal ranges. Visual evoked potentials (VEP) were abnormal due to absence of a significant response to strobe flash stimulation. However, the brainstem auditory evoked potentials were normal. A pediatric ophthalmologist noted bilateral optic atrophy. G-banding cytogenetic analysis showed a normal 46, XX karyotype. Magnetic resonance imaging of the brain was normal. The spasms were refractory to pyridoxine and valproic acid (VPA). Soon after starting adrenocorticotropic hormone therapy, the spasms disappeared; EEG showed no hypsarrhythmia, but focal spikes were apparent in the bilateral frontal areas, which resolved after adding nitrazepam (NZP) to VPA.
Subsequently, the patient was followed with unexplained West syndrome. The EEG showed focal spikes and sharp waves predominantly in the bilateral occipital areas. She had repeated generalized tonic seizures or clonic seizures associated with fever. At 14 months of age, the patient's developmental quotient (DQ) for gross motor development based on the Tsumori-Inage scale was 50, whereas that for language was below the evaluation level. The patient acquired some motor skills, such as the ability to sit on her own at 27 months. Furthermore, the VEP had improved, shown by vertex potential on the VEP at 3 years of age.
At 5 years and 9 months of age, the patient had a relapse of generalized tonic seizures and focal seizures without fever. The seizures occurred 1 to 3 times per year, and were controlled with VPA and clonazepam (CZP). She attended schools for Special Needs Education from elementary to senior high school section. After she graduated, she moved to a life-assistance facility. She finally learned to walk on her own at 20 years of age and now walks clumsily.
At present, she has yet to utter a meaningful word. She can indicate comfort or discomfort. Her DQ is less than 20, but no behavioral disturbances or sleep disorder have been seen. She has bilateral epicanthal folds, a thin upper lip, smooth philtrum, mild micrognathia, and enlarged nares. The epilepsy is controlled with CZP and VPA, and the EEG showed no obvious epileptiform discharges. Table 1 summarizes her clinical course. As described in previous report [4] , a missense mutation of NR2F1 gene (c.403C > T, p.R135C) was identified in the patient by whole-exome sequencing after informed consent.
Discussion
This case highlights the good long-term outcome of a case with West syndrome and a NR2F1 mutation, which is critical for genetic counseling.
The patient with infantile spasms reported by Michaud et al. had a missense mutation in NR2F1 at an identical position to that in [2, 3] . However, the clinical courses and long-term prognoses of these patients have not been described sufficiently (Table 1 ). In our case, the EEG and VEP improved more than 2 years and 20 years after disease onset, respectively. This suggests that the function of the cortex with a mutation in NR2F1 does not deteriorative. NR2F1 has a classical nuclear receptor structure with two main domains: a functionalDNA-binding domain (DBD) formed by two zinc-finger structural domains and a ligand-binding domain (LBD) with two highly conserved sequence regions [1] . In vitro functional expression assays with a luciferase reporter in HEK293 cells showed that all missense mutations had significantly decreased transcriptional activity compared with the wild type. These findings suggest that the heterozygous mutations identified in the affected individuals cause loss of function [1] .
Al-Kateb et al. suggested that the involvement of NR2F1 can potentially explain the developmental delay, hypotonia, epilepsy, and other neurological findings, because NR2F1 is a critical regulator of central and peripheral nervous system development and plays crucial roles in fate specification, axon guidance, arborization, axon myelination, and cortex patterning [1] .
Our case suggests that the mutations in NR2F1 encompass a broad range of clinical phenotypes. Additional patients are needed to clarify the pathophysiology and genotype-phenotype correlation, and to understand the role and influence of NR2F1 in the development of the central nervous system.
